Cancer Research Landon Prizes for Basic and Translational Cancer Research  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Claij, N.
Right arrow Articles by te Riele, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Claij, N.
Right arrow Articles by te Riele, H.
[Cancer Research 63, 2062-2066, May 1, 2003]
© 2003 American Association for Cancer Research


Carcinogenesis

DNA Mismatch Repair Deficiency Stimulates N-Ethyl-N-nitrosourea-induced Mutagenesis and Lymphomagenesis1

Nanna Claij, Anja van der Wal, Marleen Dekker, Léon Jansen and Hein te Riele2

Division of Molecular Biology, The Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands

The primary role of the mismatch repair (MMR) system is the avoidance of mutations caused by replication and recombination errors. Furthermore, the lethality of methylating agents has been attributed to the processing of O6-methylguanine lesions in DNA by MMR. Loss of the MSH2 protein completely abolishes repair function and results in reduced cell killing by methylating agents and accelerated accumulation of methylation-damage-induced mutations. This has raised the question as to whether MMR is also involved in the cellular response to other genotoxic insults. Here we describe that in mice deficient for Msh2, lymphomagenesis was strongly accelerated by an ethylating agent, N-ethyl-N-nitrosourea (ENU), given at a dose that did not induce lymphomas in wild-type mice. This suggests that MMR deficiency and ENU-induced mutagenesis synergistically collaborate in inducing tumorigenesis. To study the interaction between MMR and ENU-induced DNA damage, we compared the lethality and mutagenicity of ENU in MSH2-proficient and -deficient mouse embryonic stem cells. Although MSH2-deficiency only slightly reduced the lethality of ENU, it strongly enhanced the mutagenicity of ENU. Mutation analysis of ENU-induced Hprt mutants revealed that base substitutions occurred predominantly at A-T base-pairs. These results suggest that MMR modulates the processing of ethylation damage at AT base-pairs.




This article has been cited by other articles:


Home page
Nucleic Acids ResHome page
H. Feitsma, A. Akay, and E. Cuppen
Alkylation damage causes MMR-dependent chromosomal instability in vertebrate embryos
Nucleic Acids Res., July 1, 2008; 36(12): 4047 - 4056.
[Abstract] [Full Text] [PDF]


Home page
MutagenesisHome page
H. Feitsma, E. de Bruijn, J. van de Belt, I. J. Nijman, and E. Cuppen
Mismatch repair deficiency does not enhance ENU mutagenesis in the zebrafish germ line
Mutagenesis, July 1, 2008; 23(4): 325 - 329.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
R. van Boxtel, P. W. Toonen, H. S. van Roekel, M. Verheul, B. M. G. Smits, J. Korving, A. de Bruin, and E. Cuppen
Lack of DNA mismatch repair protein MSH6 in the rat results in hereditary non-polyposis colorectal cancer-like tumorigenesis
Carcinogenesis, June 1, 2008; 29(6): 1290 - 1297.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
P. Watson, R. Ashwathnarayan, H. T. Lynch, and H. K. Roy
Tobacco Use and Increased Colorectal Cancer Risk in Patients With Hereditary Nonpolyposis Colorectal Cancer (Lynch Syndrome)
Arch Intern Med, December 13, 2004; 164(22): 2429 - 2431.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
J. Wu, B.-B. Zhu, J. Yu, H. Zhu, L. Qiu, M. S. Kindy, L. Gu, A. Seidel, and G.-M. Li
In vitro and in vivo modulations of benzo[c]phenanthrene-DNA adducts by DNA mismatch repair system
Nucleic Acids Res., November 15, 2003; 31(22): 6428 - 6434.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2003 by the American Association for Cancer Research.